Australian Pharmaceutical Industries Ltd
ASX:API
Australian Pharmaceutical Industries Ltd
Total Equity
Australian Pharmaceutical Industries Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Australian Pharmaceutical Industries Ltd
ASX:API
|
Total Equity
AU$438.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Paragon Care Ltd
ASX:PGC
|
Total Equity
AU$329.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
24%
|
CAGR 10-Years
32%
|
|
|
Sigma Healthcare Ltd
ASX:SIG
|
Total Equity
AU$4.7B
|
CAGR 3-Years
114%
|
CAGR 5-Years
58%
|
CAGR 10-Years
24%
|
|
Australian Pharmaceutical Industries Ltd
Glance View
Australian Pharmaceutical Industries Ltd. engages in the wholesale, product delivery, retail services, marketing programs and business advisory services. The company is headquartered in Melbourne, Victoria. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The firm's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.
See Also
What is Australian Pharmaceutical Industries Ltd's Total Equity?
Total Equity
438.8m
AUD
Based on the financial report for Aug 31, 2021, Australian Pharmaceutical Industries Ltd's Total Equity amounts to 438.8m AUD.
What is Australian Pharmaceutical Industries Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
-4%
Over the last year, the Total Equity growth was -3%. The average annual Total Equity growth rates for Australian Pharmaceutical Industries Ltd have been -5% over the past three years , -4% over the past five years .
